Unresectable Esophageal Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-06-22
Clinical Trial Update: Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer [Phase 2]
Phase 2 trial updating epacadostat plus pembrolizumab in metastatic or unresectable gastroesophageal junction or gastric cancer (completed; …